Spongiform encephalopathies and prions: an overview of pathology and disease mechanisms
- PMID: 7988907
- DOI: 10.1111/j.1574-6968.1994.tb07230.x
Spongiform encephalopathies and prions: an overview of pathology and disease mechanisms
Abstract
The etiology of spongiform encephalopathies has been sharply contested for decades. At the heart of the issue is the question of disease origin: Are prion disease representative of primary neurodegenerative genetic disorders, or are they bona fide infectious diseases? This article provides a brief outline of the progress made in the elucidation of prion disease mechanisms in the context of pathological support of the 'protein only' hypothesis. The answer to the above question appears to be that spongiform encephalopathies are uniquely both infectious and genetic neurodegenerative diseases.
Similar articles
-
Transmissible spongiform encephalopathies: prion proof in progress.Nature. 2004 Aug 26;430(7003):977-9. doi: 10.1038/430977a. Nature. 2004. PMID: 15329705 No abstract available.
-
[The non-conventional transmissible agents at the origin of transmissible subacute spongiform encephalopathies].Therapie. 1998 Mar-Apr;53(2):93-100. Therapie. 1998. PMID: 9773107 Review. French.
-
Mouse models of prion disease transmission.Trends Mol Med. 2002 Oct;8(10):495-500. doi: 10.1016/s1471-4914(02)02416-4. Trends Mol Med. 2002. PMID: 12383773 Review.
-
Prions and prion diseases: fundamentals and mechanistic details.J Microbiol Biotechnol. 2007 Jul;17(7):1059-70. J Microbiol Biotechnol. 2007. PMID: 18051314 Review.
-
Transgenesis applied to transmissible spongiform encephalopathies.Transgenic Res. 2002 Dec;11(6):547-64. doi: 10.1023/a:1021125510220. Transgenic Res. 2002. PMID: 12509129 Review.
Cited by
-
Activation of p53-regulated pro-apoptotic signaling pathways in PrP-mediated myopathy.BMC Genomics. 2009 Apr 28;10:201. doi: 10.1186/1471-2164-10-201. BMC Genomics. 2009. PMID: 19400950 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources